期刊文献+

氨酚羟考酮片与盐酸羟考酮缓释片在晚期癌痛治疗的药物经济学分析 被引量:9

Pharmacoeconomic analysis of Oxycodone and Acetaminophen Tablets and Oxycodone Hydrochloride Prolonged-Release Tablets in treatment of advanced cancer pain
下载PDF
导出
摘要 目的:比较氨酚羟考酮片(泰勒宁)与盐酸羟考酮缓释片(奥施康定)用于晚期癌痛患者镇痛治疗的成本-效果,为临床用药提供指导。方法:选取晚期癌痛患者148例,其中泰勒宁组73例,奥施康定组75例,比较用药4周后的镇痛疗效、不良反应及用药成本,运用药物经济学成本-效果分析法评价两组治疗方案。结果:泰勒宁组镇痛治疗总有效率为86.3%,奥施康定组为90.7%,两组间疗效差异无统计学意义(P>0.05),泰勒宁组的不良反应发生率较奥施康定组低。成本/效果比(C/E)泰勒宁组为1861,奥施康定组为2878。结论:泰勒宁和奥施康定用于晚期癌痛患者镇痛治疗疗效相当,泰勒宁治疗成本较低,奥施康定不良反应较高。 Objective:To assess the cost-effect ratio of Oxycodone and Acetaminophen Tablets(Tylox) and Oxycodone Hydrochloride Prolonged-Release Tablets(OXY-contin) in the treatment of advanced cancer pain to provide the direction for clinical medication.Methods:148 patients with advanced cancer pain were treated by Tylox(n=73) or OXY-contin(n=75).After 4 weeks of treatment,the efficacy,adverse reactions and cost-effect ratio were evaluated and compared between the two groups.Results:The effective rates was 86.3% in Tylox group and 90.7% in OXY-contin group without significant difference(P0.05).The incidence of adverse reactions in Tylox group was lower than that in OXY-contin group.The cost-effect ratio was 1861 in Tylox group and 2878 in OXY-contin group.Conclusion:The efficacy of Tylox and OXY-contin is similar.The cost-effect ratio of Tylox is lower and the adverse reactions of OXY-contin is higher.
出处 《现代医药卫生》 2011年第21期3242-3243,共2页 Journal of Modern Medicine & Health
关键词 氨酚羟考酮片 盐酸羟考酮缓释片 癌症疼痛 镇痛 药物经济学 Oxycodone and Acetaminophen Tablet Oxycodone Hydrochloride Prolonged-Release Tablet Cancer pain Relieve pain Pharmacoeconomics
  • 相关文献

参考文献9

  • 1水源 樊碧发.癌痛治疗的新进展.中国疼痛医学杂志,2005,.
  • 2邬东儿,俞恩珠.癌痛患者的三阶梯药物镇痛治疗分析[J].中国药物滥用防治杂志,2007,13(3):171-171. 被引量:11
  • 3周英娣.癌痛治疗误区分析[J].实用中医药杂志,2005,21(2):113-113. 被引量:2
  • 4石远凯.,临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2007:251.
  • 5徐建国,于世英.麻醉药品和精神药品规范化临床应用与管理[M].北京:人民卫生出版社,2007:10.
  • 6高钧,赵国伟,周宁.氨酚羟考酮片用于疼痛治疗的回顾性分析[J].中国新药杂志,2007,16(16):1308-1310. 被引量:28
  • 7Stockler M, Vardy J, Piliai A, et al proves pain and well-being in people with advanced cancer already receiving a strong opioid regimen a randomized double-blind placebo-controlled cross-over trial[J].J Clin Oncol, 2004,22(16) : 3389.
  • 8Gammaitoni AR, Galer BS, Bulloch S,et al. Randomized, doubleblind placebo-controlled comparison of the analgesic efficacy of oxycodone 10rag/acetaminophen 325mg versus controlled-release oxyeodone 20mg in postsurgical pain[J].J Clin Pharmacol, 2003,43(3):296.
  • 9李小梅,刘端祺.癌痛治疗指南解析[J].医学与哲学(B),2009,30(2):15-17. 被引量:40

二级参考文献16

  • 1陈战,刘晓娟,林大富,涂永久.泰勒宁片纳肛对肛肠疾病术后镇痛效果观察[J].临床军医杂志,2004,32(4):18-19. 被引量:19
  • 2刘国辉,杨述华,张玉.氨酚羟考酮片的临床应用评价[J].中国药学杂志,2005,40(6):468-468. 被引量:14
  • 3周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1998.463.
  • 4BEAVER WT,MCMILLAN D.Methodological considerations in the evaluation of analgesic combinations:acetaminophen (paracetamol) and hydrocodone in postpartum pain[J].Br J Clin Pharmacol,1980,10 (Suppl):215-223.
  • 5GAMMAITONI AR,GALER BS,BULLOCH S,et al.Randomized,double-blind,placebo-controlled comparison of the analgesic efficacy of oxycodone 10mg/acetaminophen 325mg versus controlledrelease oxycodone 20mg in postsurgical pain[J].J Clin Pharmacol,2003,43 (3):296-304.
  • 6Deandrea S,Montanari M,Moja L G,et al.Prevalence of under-treat ment in cancer pain.Areviewof published literature[].An-nals of Oncology.2008
  • 7Singapore Ministry of Health.Cancer pain[]..2003
  • 8European Association of Urology.Guideline on pain management[]..2007
  • 9Hospice Africa.Pain and symptom control in the cancer and/or AIDS patient in Uganda and other African countries[]..2006
  • 10.World Health Organization guidelines for cancer pain:a reapprais-al[].Annals of Oncology.2005

共引文献115

同被引文献92

引证文献9

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部